Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A

BSX.PRA

Market cap $973M

BSX.PRA Hedge Fund Activity: Q1 2022 in Review

44 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q1 2022, worth a combined $1.11B — up 0.92% from $1.1B a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of BSX.PRA and 6 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 12 added.

The largest buyer was Allianz Asset Management, adding an estimated $31.2M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $17.2M sold.

• 44 institutional investors held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q1 2022, down from 47 in Q4 2021.
• Funds reported $1.11B of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q1 2022, up 0.92% quarter-over-quarter.
• 6 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q1 2022 and 9 closed out, a net change of -3 holders.
• The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A buyer in Q1 2022 was Allianz Asset Management, an estimated $31.2M added.
• The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q1 2022 was Janus Henderson Group, an estimated $17.2M sold.

Based on aggregated 13F filings for Q1 2022.